MARKET

HROW

HROW

Harrow Health Inc
NASDAQ
25.09
+0.27
+1.09%
Opening 11:55 07/17 EDT
OPEN
24.44
PREV CLOSE
24.82
HIGH
25.43
LOW
24.44
VOLUME
121.94K
TURNOVER
0
52 WEEK HIGH
25.43
52 WEEK LOW
7.60
MARKET CAP
887.73M
P/E (TTM)
-27.6382
1D
5D
1M
3M
1Y
5Y
1D
Harrow Health (HROW) Gets a Buy from Craig-Hallum
TipRanks · 2d ago
Weekly Report: what happened at HROW last week (0708-0712)?
Weekly Report · 2d ago
15 Healthcare Stocks Hit New Highs: Did You Spot These Winners?
NASDAQ · 3d ago
HARROW TO ATTEND 2024 ASRS ANNUAL MEETING
Reuters · 5d ago
Harrow Enters Into 340B Prime Vendor Program Contract With Apexus
Benzinga · 07/09 11:11
Noteworthy Monday Option Activity: HUBS, HROW, SQ
NASDAQ · 07/08 19:21
Weekly Report: what happened at HROW last week (0701-0705)?
Weekly Report · 07/08 11:46
Top 3 Health Care Stocks That May Crash This Quarter
Three stocks in the health care sector are considered overbought. The RSI is a momentum indicator that compares a stock's strength on days when prices go up to its weakness. Harrow Inc is one of the three stocks with a RSI value of 75. The company's stock gained 22% over the past month.
Benzinga · 07/03 13:41
More
About HROW
Harrow, Inc. is an eyecare pharmaceutical company. The Company is engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the United States market. It provides a comprehensive portfolio of prescription and non-prescription pharmaceutical products. It owns commercial rights to portfolios of branded ophthalmic pharmaceutical products in North America, all of which are marketed under the Harrow name. It owns and operates ImprimisRx, an ophthalmology-focused pharmaceutical-compounding business. It owns United States commercial rights to various products: IHEEZO, VEVYE, TRIESENCE, VIGAMOX, ILEVRO, FLAREX, NATACYN, ZERVIATE and others. VIGAMOX (moxifloxacin hydrochloride ophthalmic solution) 0.5%, a fluoroquinolone antibiotic eye drops for the treatment of bacterial conjunctivitis caused by susceptible strains of organisms. IHEEZO (chloroprocaine hydrochloride ophthalmic gel) 3% is a low-viscosity gel indicated for ocular surface anesthesia.

Webull offers Harrow Inc stock information, including NASDAQ: HROW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HROW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HROW stock methods without spending real money on the virtual paper trading platform.